Search Results 531-540 of 18199 for Immunode

1. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

   Known history of testing positive for human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (AIDS). Allergies and Adverse Drug ...

2. Validation of The NEPHROCLEARTM CCL14 Test in the Intensive Care Unit (ICU) for Risk Assessment of Persistent Severe Acute Kidney Injury - Mayo Clinic

   Known infection with human immunodeficiency virus (HIV) or active hepatitis (acute or chronic). NOTE: HIV or hepatitis testing need not be performed for ...

3. A Study to Validate Patient-Reported Outcome Instruments in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection - Mayo Clinic

   - Known or suspected acquired immunodeficiency syndromes (HIV-positive, regardless of. CD4 counts). Other immunodeficiency syndromes that may interfere with ...

4. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (dosing exceeding 10 mg daily of prednisone equivalent) or any other ...

5. Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients with Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   No human immunodeficiency virus (HIV) infection; patients with immune dysfunction are at a significantly higher risk of toxicities from intensive ...

6. Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis - Mayo Clinic

   Uncontrolled infection. Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive and currently receiving ...

7. Study To Evaluate The Efficacy And Safety Of Ersodetug In Patients With Inadequately Controlled Hypoglycemia Due To Tumor-Associated Hyperinsulinism - Mayo Clinic

   Seropositivity, indicative of active infection for human immunodeficiency virus, hepatitis B, or hepatitis C (excluding immunization patterns). Major ...

8. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

9. Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304) - Mayo Clinic

   Has a diagnosis of immunodeficiency or has a known history of human immunodeficiency virus (HIV) infection, Hepatitis B infection or known active Hepatitis C ...

10. Publications - Amer N. Kalaaji, M.D. - Mayo Clinic

    The relevance of lymphoid cell migration to immunodeficiency syndromes. Lymphology. 1990 Jun; 23(2):64-72. View PubMed; Kalaaji AN, McCullough K, Hay JB. The ...